BE Therapeutics
PrivateLast Round
Seed
Nov 16, 2023
Total Funding Raised
$3.6M
Company Overview
BE Therapeutics is a biotechnology company that develops regenerative medicine therapies designed to repair and restore damaged brain and spinal cord tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BE Therapeutics Comparables
Compare BE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innervace | 81% | |
| Spiderwort | 78% | |
| UCB | 77% |
BE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 16, 2023 |
BE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Empire State Development | Seed |
| Longevitytech.fund | Seed |
| Healthspan Capital | Seed |
| Alumni Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2024
Grew 133% QoQ, from 3 to 7 employees.
- Apr 27, 2024
Grew 250% QoQ, from 2 to 7 employees.
BE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BE Therapeutics's valuation, stock price, and market status.
Is BE Therapeutics a public or private company?
BE Therapeutics is a private company.
What is the current stock price of BE Therapeutics?
BE Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is BE Therapeutics worth (valuation)?
Valuation information for BE Therapeutics is not publicly available.
Can I buy BE Therapeutics stock?
BE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BE Therapeutics's last funding round?
Funding round information for BE Therapeutics is not publicly available.
Who are the main investors in BE Therapeutics?
Investor information for BE Therapeutics is not publicly disclosed.
Will BE Therapeutics IPO soon?
No public IPO plans have been announced for BE Therapeutics.
How can I track BE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BE Therapeutics's secondary market activity and sign up for updates.